Tuesday, May 07 2024
10:20 AM – 10:44 AM ET - Ballroom 2
Targeting aberrant glycosylation in tumors
Avery Posey - PhD
University of Pennsylvania
Disclosures: A.D. Posey: 1; Commercial Interest i.e. Company X; Astellas Pharma. 1; What was received? i.e. Honorarium; Consulting fees, Grant funding. 1; For what role? i.e. Speaker; Scientific advisor, Research support. 2; Commercial Interest i.e. Company X; Maxcyte. 2; What was received? i.e. Honorarium; Consulting fees. 2; For what role? i.e. Speaker; Scientific advisor. 3; Commercial Interest i.e. Company X; ImmunoACT. 3; What was received? i.e. Honorarium; Consulting fees. 3; For what role? i.e. Speaker; Scientific advisor.